市场调查报告书
商品编码
1541316
2024-2032 年按产品、应用和地区分類的家庭输液治疗市场报告Home Infusion Therapy Market Report by Product, Application, and Region 2024-2032 |
IMARC Group年,全球家庭输液治疗市场规模达432亿美元。慢性病盛行率的上升、对家庭医疗保健的日益偏好以及持续的产品创新是推动市场发展的一些关键因素。
居家输液治疗是一种专门的医疗治疗,涉及透过帮浦、导管和小瓶等各种设备,在舒适的家中向患者静脉注射药物,例如抗病毒药物或免疫球蛋白、液体或营养物。建议患有感染、癌症或需要长期或频繁输液治疗的慢性疾病(如多发性硬化症 (MS) 或类风湿性关节炎)的患者使用。家庭输液治疗提供舒适和便利,提高生活质量,并降低医院获得性感染的风险。除此之外,它还允许患者在接受必要的医疗照护的同时,保持对治疗的独立感和控制感。居家输液疗法在化疗和水合、肠内、正性肌力、抗感染、营养和疼痛管理疗法中非常有效,主要用于治疗糖尿病和各种胃肠道和肿瘤疾病。
患有癌症、骨关节炎、人类免疫缺陷病毒(HIV)和糖尿病等慢性病的人数增加是推动市场成长的主要因素之一。同时,容易患危及生命疾病并需要定期医疗(例如输液治疗)的老年人口的增加正在对市场成长产生积极影响。此外,众多政府措施和优惠报销政策的实施以及延长住院费用的飙升促使患者选择家庭输液治疗,这反过来又促进了市场的成长。除此之外,由于家庭医疗保健服务的便利性和成本效益,人们对家庭医疗保健服务的偏好发生了转变,以及医院对空间和床位的需求不断增长,正在加强市场的成长。与此一致的是,由于长期接触受污染的设备、床单和空气飞沫而导致的医院获得性感染(HAI)盛行率不断上升,这有助于市场扩张。除此之外,对需要专门管理的特殊药物的广泛需求是另一个重要的成长诱导因素。此外,创新技术的进步,例如开发配备先进滴注系统的轻型、便携式和易于使用的输液泵,用于精确和即时监测静脉注射治疗,正在为市场带来有利可图的成长机会。
The global home infusion therapy market size reached US$ 43.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The rising prevalence of chronic diseases, the increasing preference for home healthcare, and ongoing product innovations represent some of the key factors driving the market.
Home infusion therapy is a specialized medical treatment involving the administration of medication, such as antivirals or immune globin, fluids, or nutrition intravenously through various equipment, including pumps, catheters, and vials, to patients in the comfort of their homes. It is recommended for patients with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis requiring long-term or frequent infusion therapy. Home infusion therapy offers comfort and convenience, improves the quality of life, and reduces the risk of hospital-acquired infections. In addition to this, it allows patients to maintain a sense of independence and control over their treatment while still receiving the necessary medical care. Home infusion therapy is highly effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies that are primarily used for treating diabetes and various gastrointestinal and oncological disorders.
The rise in the number of people suffering from chronic diseases, such as cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes, represents one of the prime factors driving the market growth. Concurrent with this, the increase in the geriatric population prone to life-threatening diseases and requiring regular medical attention, such as infusion therapy, is positively impacting the market growth. Moreover, the implementation of numerous government initiatives and favorable reimbursement policies and the surging costs of extended hospital stays are prompting patients to opt for home infusion therapy, which, in turn, is contributing to the market growth. Besides this, the shifting preference for home healthcare services due to their convenience and cost-effectiveness and the growing need for space and beds in hospitals are strengthening the market growth. In line with this, the rising prevalence of hospital-acquired infections (HAIs) due to elongated exposure to contaminated equipment, bed linens, and air droplets is aiding in market expansion. In addition to this, the widespread demand for specialty drugs which require specialized administration is acting as another significant growth-inducing factor. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and easy-to-use infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are presenting remunerative growth opportunities for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global home infusion therapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and application.
Infusion Pumps
Elastomeric
Electromechanical
Gravity
Others
Intravenous Sets
IV Cannulas
Needleless Connectors
The report has provided a detailed breakup and analysis of the home infusion therapy market based on the product. This includes infusion pumps (elastomeric, electromechanical, gravity, and others), intravenous sets, IV cannulas, and needleless connectors. According to the report, infusion pumps represented the largest segment.
Anti-Infective
Endocrinology
Diabetes
Others
Hydration Therapy
Athletes
Others
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others
A detailed breakup and analysis of the home infusion therapy market based on the application has also been provided in the report. This includes anti-infective, endocrinology (diabetes and others), hydration therapy (athletes and others), chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. According to the report, anti-infectives accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for home infusion therapy. Some of the factors driving the North America home infusion therapy market included the expanding prevalence of cancer, HIV, and diabetes, the widespread adoption of home healthcare, and numerous technological advancements in the industry.
The report has also provided a comprehensive analysis of the competitive landscape in the global home infusion therapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc, and Terumo Corporation. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.